Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Rises After Drugs Combat Skin, Blood Malignancies
Bloomberg
Monday, June 7, 2010 - 9:54am
tags:
Bristol-Myers Squibb, Sprycel, leukemia, Gleevec, Novartis
Novartis study shows Afinitor shrinks brain tumors
Yahoo/AP
Monday, June 7, 2010 - 9:51am
tags:
Afinitor, brain tumors
AstraZeneca reports positive Phase III study
Marketwatch
Monday, June 7, 2010 - 9:50am
tags:
AstraZeneca, thyroid cancer, vandetanib
One More Way To Minimize The Sales Rep?
Pharmalot
Monday, June 7, 2010 - 8:49am
tags:
sales reps, Pfizer, drug reps, iPhone, Epocrates
Abraxis' Abraxane meets cancer study goal
Yahoo/AP
Monday, June 7, 2010 - 8:48am
tags:
companies, Abraxane, lung cancer
Erbitux Fails to Stop Colon Cancer Before It Spreads
Bloomberg
Monday, June 7, 2010 - 8:44am
tags:
Erbitux, colon cancer, Eli Lilly, Merck KGaA
Novartis, Sanofi Pursue ‘Cash Machine’ in Indian Countryside
Bloomberg
Monday, June 7, 2010 - 8:44am
tags:
India, Novartis, Sanofi
Good News for Big Pharma at ASCO
Yahoo/Indie Research
Monday, June 7, 2010 - 8:43am
tags:
ACSCO, Big Pharma, Baxter International, Bristol-Myers Squibb, Amgen, Eli Lilly, Pfizer
ZymoGenetics skin cancer drug meets study goal
Yahoo/AP
Monday, June 7, 2010 - 8:04am
tags:
ZymoGenetics, skin cancer, Interleukin
ArQule says drug candidate could benefit subgroup of lung cancer patients
Yahoo/AP
Monday, June 7, 2010 - 8:03am
tags:
lung cancer, Arqule
Drug Industry Spends Billions On Free Samples Of Popular Meds
NASDAQ.com
Monday, June 7, 2010 - 7:59am
tags:
samples
Grifols Agrees to Buy Talecris for $3.4 Billion
Bloomberg
Monday, June 7, 2010 - 7:58am
tags:
Grifols, M&A, Talecris
AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
BNET Pharma
Monday, June 7, 2010 - 7:55am
tags:
AstraZeneca, FDA, copycat drugs, RSV, Synagis, Rezield
Roche’s Avastin Delays Worsening of Advanced Ovarian Cancer
Bloomberg
Monday, June 7, 2010 - 7:53am
tags:
ovarian cancer, Avastin, Roche
Dividend, Beta Make Johnson & Johnson Attractive in a Downturn
TheStreet.com
Monday, June 7, 2010 - 7:52am
tags:
dividends, JNJ
Pfizer CEO: Excited About New Lung Cancer Drug
CNBC
Monday, June 7, 2010 - 7:51am
tags:
Pfizer, lung cancer, crizotinib, Jeff Kindler, Pharma CEOs
The Risk For Bristol
Forbes
Monday, June 7, 2010 - 7:48am
tags:
Bristol-Myers Squibb, melanoma, ASCO, ipilimumab
Randomized Phase III Study Comparing REVLIMID(R) Plus Melphalan and Prednisone (MPR) Compared to Autologous Stem Cell Transplant Presented at ASCO
MarketWatch
Sunday, June 6, 2010 - 12:34pm
tags:
Multiple Myeloma, Revlimid, melphalan, autologous stem cell transplant, Celgene
Phase III Study Results Showed Eisai’s Eribulin Mesylate Significantly Improved Overall Survival in Patients with Locally Recurrent or Metastatic Breast Cancer
BusinessWire
Sunday, June 6, 2010 - 12:31pm
tags:
Eisai, Eribulin Mesylate, breast cancer
Researchers Report Treatment Headway Against Lung Cancer
BusinessWeek
Sunday, June 6, 2010 - 11:52am
tags:
crizotinib, non-small cell lung cancer, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.